UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 7.068

Sortiert nach

FGFR3 protein expression and its relationship to mutation status and prognostic variables in bladder cancer

The Journal of pathology, 2007-09, Vol.213 (1), p.91-98

2007

Volltextzugriff (PDF)

Small molecule FGF receptor inhibitors block FGFR-dependent urothelial carcinoma growth in vitro and in vivo

British journal of cancer, 2011-01, Vol.104 (1), p.75-82

2011

Volltextzugriff (PDF)

Mechanisms of FGFR3 actions in endocrine resistant breast cancer

International journal of cancer, 2012-06, Vol.130 (12), p.2857-2866

2012

Volltextzugriff (PDF)

Mutant fibroblast growth factor receptor 3 induces intracellular signaling and cellular transformation in a cell type- and mutation-specific manner

Oncogene, 2009-12, Vol.28 (48), p.4306-4316

2009

Volltextzugriff (PDF)

Knockdown by shRNA identifies S249C mutant FGFR3 as a potential therapeutic target in bladder cancer

Oncogene, 2007-08, Vol.26 (40), p.5889-5899

2007

Volltextzugriff (PDF)

Hypoxia regulates FGFR3 expression via HIF-1α and miR-100 and contributes to cell survival in non-muscle invasive bladder cancer

British journal of cancer, 2013-07, Vol.109 (1), p.50-59

2013

Volltextzugriff (PDF)

PIK3CA mutation spectrum in urothelial carcinoma reflects cell context-dependent signaling and phenotypic outputs

Oncogene, 2013-02, Vol.32 (6), p.768-776

2013

Volltextzugriff (PDF)

AKT1 mutations in bladder cancer: identification of a novel oncogenic mutation that can co-operate with E17K

Oncogene, 2010-01, Vol.29 (1), p.150-155

2010

Volltextzugriff (PDF)

PIK3CA dependence and sensitivity to therapeutic targeting in urothelial carcinoma

BMC cancer, 2016-07, Vol.16 (1), p.553-553, Article 553

2016

Volltextzugriff (PDF)

Next-generation sequencing identifies germline MRE11A variants as markers of radiotherapy outcomes in muscle-invasive bladder cancer

Annals of oncology, 2014-04, Vol.25 (4), p.877-883

2014

Volltextzugriff (PDF)

Inactivation of the Rb pathway and overexpression of both isoforms of E2F3 are obligate events in bladder tumours with 6p22 amplification

Oncogene, 2008-04, Vol.27 (19), p.2716-2727

2008

Volltextzugriff (PDF)

Putative tumour suppressor gene necdin is hypermethylated and mutated in human cancer

British journal of cancer, 2013-04, Vol.108 (6), p.1368-1377

2013

Volltextzugriff (PDF)

The genetics of transitional cell carcinoma: progress and potential clinical application

BJU international, 1999-09, Vol.84 (4), p.412-427

KNOWLES, M. A

1999

Volltextzugriff (PDF)

Expression of NRG1 and its receptors in human bladder cancer

British journal of cancer, 2011-03, Vol.104 (7), p.1135-1143

2011

Volltextzugriff (PDF)

Expression of hTERT immortalises normal human urothelial cells without inactivation of the p16 Rb pathway

Oncogene, 2006-08, Vol.25 (36), p.5037-5045

2006

Volltextzugriff (PDF)

Somatic mutation of PTEN in bladder carcinoma

British journal of cancer, 1999-05, Vol.80 (5-6), p.904-908

1999

Volltextzugriff (PDF)

What we could do now: molecular pathology of bladder cancer

Molecular pathology, 2001-08, Vol.54 (4), p.215-221

Knowles, M A

2001

Volltextzugriff (PDF)

Tuberous sclerosis complex (TSC) gene involvement in sporadic tumours

Biochemical Society transactions, 2003-06, Vol.31 (Pt 3), p.597

2003

Volltextzugriff (PDF)

Protein shedding in urothelial bladder cancer: prognostic implications of soluble urinary EGFR and EpCAM

British journal of cancer, 2015-03, Vol.112 (6), p.1052-1058

2015

Volltextzugriff (PDF)

DBC1 re-expression alters the expression of multiple components of the plasminogen pathway

Oncogene, 2006-04, Vol.25 (16), p.2409-2419

2006

Volltextzugriff (PDF)

DAP-kinase loss of expression in various carcinoma and B-cell lymphoma cell lines : possible implications for role as tumor suppressor gene

Oncogene, 1997-07, Vol.15 (4), p.403-407

1997

Volltextzugriff (PDF)

Inhibition of double-strand break non-homologous end-joining by cisplatin adducts in human cell extracts

Nucleic acids research, 2005-01, Vol.33 (8), p.2531

2005

Volltextzugriff (PDF)

Mutation of the 9q34 gene TSC1 in sporadic bladder cancer

Oncogene, 1999-04, Vol.18 (16), p.2657-2661

1999

Volltextzugriff (PDF)

Destabilization of chromosome 9 in transitional cell carcinoma of the urinary bladder

British journal of cancer, 2001-12, Vol.85 (12), p.1887-1893

2001

Volltextzugriff (PDF)

1 – 25 von 7.068

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(5.706)
Mit Volltextzugriff
(5.948)

Publikationsform

4 weitere anzeigen...

Weniger anzeigen...

Sprache

5 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(3.728)
Life Sciences & Biomedicine
(2.723)
Humans
(2.040)
Biological And Medical Sciences
(1.140)
Male
(1.029)
Female
(1.021)
Animals
(865)
Medical Sciences
(729)
Adult
(630)
Physical Sciences
(586)
Middle Aged
(526)
Technology
(472)
Fundamental And Applied Biological Sciences. Psychology
(467)
Aged
(396)
Physics
(392)
Biochemistry & Molecular Biology
(384)
Materials Science
(304)
Chemistry
(299)
Adolescent
(297)
Science & Technology - Other Topics
(266)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

FGFR3 protein expression and its relationship to mutation status and prognostic variables in bladder cancer

Small molecule FGF receptor inhibitors block FGFR-dependent urothelial carcinoma growth in vitro and in vivo

Mechanisms of FGFR3 actions in endocrine resistant breast cancer

Mutant fibroblast growth factor receptor 3 induces intracellular signaling and cellular transformation in a cell type- and mutation-specific manner

Knockdown by shRNA identifies S249C mutant FGFR3 as a potential therapeutic target in bladder cancer

Hypoxia regulates FGFR3 expression via HIF-1α and miR-100 and contributes to cell survival in non-muscle invasive bladder cancer

PIK3CA mutation spectrum in urothelial carcinoma reflects cell context-dependent signaling and phenotypic outputs

AKT1 mutations in bladder cancer: identification of a novel oncogenic mutation that can co-operate with E17K

PIK3CA dependence and sensitivity to therapeutic targeting in urothelial carcinoma

Next-generation sequencing identifies germline MRE11A variants as markers of radiotherapy outcomes in muscle-invasive bladder cancer

Inactivation of the Rb pathway and overexpression of both isoforms of E2F3 are obligate events in bladder tumours with 6p22 amplification

Putative tumour suppressor gene necdin is hypermethylated and mutated in human cancer

The genetics of transitional cell carcinoma: progress and potential clinical application

Expression of NRG1 and its receptors in human bladder cancer

Expression of hTERT immortalises normal human urothelial cells without inactivation of the p16 Rb pathway

Somatic mutation of PTEN in bladder carcinoma

What we could do now: molecular pathology of bladder cancer

Tumor heterogeneity of fibroblast growth factor receptor 3 (FGFR3) mutations in invasive bladder cancer: implications for perioperative anti-FGFR3 treatment

Tuberous sclerosis complex (TSC) gene involvement in sporadic tumours

Protein shedding in urothelial bladder cancer: prognostic implications of soluble urinary EGFR and EpCAM

DBC1 re-expression alters the expression of multiple components of the plasminogen pathway

DAP-kinase loss of expression in various carcinoma and B-cell lymphoma cell lines : possible implications for role as tumor suppressor gene

Inhibition of double-strand break non-homologous end-joining by cisplatin adducts in human cell extracts

Mutation of the 9q34 gene TSC1 in sporadic bladder cancer

Destabilization of chromosome 9 in transitional cell carcinoma of the urinary bladder

Suchergebnisse filtern